<DOC>
	<DOCNO>NCT01992198</DOCNO>
	<brief_summary>Strategy antibiotic therapy SAP , De-escalate ( cefoperazone+metronidazole ) Escalate ( meropenem ) therapy , one good .</brief_summary>
	<brief_title>Multi-center Clinical Study Early Antibios Severe Acute Pancreatitis</brief_title>
	<detailed_description>SAP serious life-threatening disease require intensive aggressive management multiple organ failure severe infectious complication develop patient . The common cause death patient suffer severe acute pancreatitis ( SAP ) infection pancreatic necrosis enteric bacteria mortality rate 30 % ( range 14- 62 % ) , spur discussion whether prophylactic antibiotic administration could beneficial approach . Pancreatic infection often monomicrobial , especially E. coli two first week ( 100 % 62.5 % ) onset , shift gram-negative gram-positive pancreatitis progress . In order evaluate benefit prophylactic antibiotic application , number randomize controlled clinical trial publish past 15 year . Since result conflict study low methodological quality and/or statistically underpowered , meta-analyses perform assess important issue . However , result range absolutely effect antibiotic prophylaxis positive effect regard mortality , incidence infect pancreatic necrosis incidence extra pancreatic infection . In order provide reliable evidence effect antibiotherapy strategy SAP , perform prospective randomize multicenter clinical trial .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis , Acute Necrotizing</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Cefoperazone</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Sulperazone</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>severe Acute Pancreatitis accord Atlanta criterion revisit 2012 concurrent sepsis ( peri ) pancreatic infection cause second disease patient chronic organ failure ( chronic renal failure need kidney replacement , chronic heart failure , decompensate hepatic cirrhosis , chronic obstructive pulmonary disease ) recurrent endoscopic retrograde cholangiopancreatography ( ERCP ) , traumatic operative pancreatitis pregnancy , malignancy immunodeficiency history allergy meropenem , cefoperazone metronidazole history antibiotic administration within 48 h prior enrollment possible death within 48 h enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>antibiothearpy strategy</keyword>
	<keyword>cefoperazone</keyword>
	<keyword>metronidazole</keyword>
	<keyword>meropenem</keyword>
</DOC>